Compared with normal liver cells (i.e., HepaRG), Sp1 expression was significantly increased 4.4‐ and 3.7‐fold (Fig. 4B) in PLC/PRF/5 (P < 0.001) and HepG2 (P = 0.001) liver cancer cells. Here, SP1 is linked to liver cancer.